DK2035451T3 - Insulinoptrop peptidsyntese - Google Patents

Insulinoptrop peptidsyntese

Info

Publication number
DK2035451T3
DK2035451T3 DK07765481.2T DK07765481T DK2035451T3 DK 2035451 T3 DK2035451 T3 DK 2035451T3 DK 07765481 T DK07765481 T DK 07765481T DK 2035451 T3 DK2035451 T3 DK 2035451T3
Authority
DK
Denmark
Prior art keywords
insulinoptrop
peptide synthesis
peptide
synthesis
insulinoptrop peptide
Prior art date
Application number
DK07765481.2T
Other languages
English (en)
Inventor
Lin Chen
Yeun-Kwei Han
Christopher R Roberts
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK2035451T3 publication Critical patent/DK2035451T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK07765481.2T 2006-06-23 2007-06-19 Insulinoptrop peptidsyntese DK2035451T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81591906P 2006-06-23 2006-06-23
PCT/EP2007/056052 WO2007147816A1 (en) 2006-06-23 2007-06-19 Insulinotropic peptide synthesis

Publications (1)

Publication Number Publication Date
DK2035451T3 true DK2035451T3 (da) 2010-06-07

Family

ID=38596729

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07765481.2T DK2035451T3 (da) 2006-06-23 2007-06-19 Insulinoptrop peptidsyntese

Country Status (33)

Country Link
US (2) US20080004429A1 (da)
EP (1) EP2035451B1 (da)
JP (1) JP4537495B2 (da)
KR (1) KR101087859B1 (da)
CN (1) CN101563364B (da)
AR (1) AR061604A1 (da)
AT (1) ATE466881T1 (da)
AU (1) AU2007263043B2 (da)
BR (1) BRPI0713575A2 (da)
CA (1) CA2654610C (da)
CL (1) CL2007001835A1 (da)
CR (1) CR10463A (da)
CY (1) CY1110186T1 (da)
DE (1) DE602007006310D1 (da)
DK (1) DK2035451T3 (da)
EC (1) ECSP088999A (da)
ES (1) ES2341588T3 (da)
HR (1) HRP20100302T1 (da)
IL (1) IL195421A0 (da)
MA (1) MA30530B1 (da)
MX (1) MX2008015935A (da)
MY (1) MY144608A (da)
NO (1) NO20084863L (da)
NZ (1) NZ573093A (da)
PL (1) PL2035451T3 (da)
PT (1) PT2035451E (da)
RS (1) RS51281B (da)
RU (1) RU2448978C2 (da)
SI (1) SI2035451T1 (da)
TW (1) TWI331155B (da)
UA (1) UA96602C2 (da)
WO (1) WO2007147816A1 (da)
ZA (1) ZA200810072B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5473925B2 (ja) 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
EP2222695A2 (en) * 2007-12-11 2010-09-01 F. Hoffmann-La Roche AG Insulinotropic peptide synthesis using solid and solution phase combination techniques
US20100317057A1 (en) * 2007-12-28 2010-12-16 Novo Nordisk A/S Semi-recombinant preparation of glp-1 analogues
US20100183876A1 (en) * 2008-12-23 2010-07-22 Hell Andre Process for the Preparation of a Peptide Powder Form
CN102414220A (zh) * 2009-05-01 2012-04-11 霍夫曼-拉罗奇有限公司 使用固相和液相组合技术的促胰岛素肽合成
US20110313131A1 (en) 2010-06-21 2011-12-22 Christelle Carl Reversed phase hplc purification of a glp-1 analogue
US20120157382A1 (en) 2010-12-21 2012-06-21 Siegfried Krimmer Pharmaceutical glp-1 compositions having an improved release profile
DK2788110T3 (da) * 2011-12-08 2019-02-11 Pentair Water Pool & Spa Inc Akvakultursystem og fremgangsmåde til at betjene en pumpe i sådan et system
RU2643515C2 (ru) 2011-12-29 2018-02-02 Ново Нордиск А/С Дипептид, содержащий непротеиногенную аминокислоту
CN104936610A (zh) 2012-11-13 2015-09-23 益普生制药股份有限公司 Glp-1类似物的纯化方法
WO2014077801A1 (en) 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Purification process for preparing highly pure taspoglutide
GR20140100479A (el) * 2014-09-23 2016-05-05 Novetide, Ltd., Συνθεση λιραγλουτιδης
CA3093221A1 (en) 2018-03-09 2019-09-12 Enzypep B.V. Chemo-enzymatic synthesis of liraglutide, semaglutide and glp-1
EP3762408A1 (en) 2018-03-09 2021-01-13 Enzypep B.V. Chemo-enzymatic synthesis of semaglutide, liraglutide and glp-1
ES2938734T3 (es) * 2018-10-09 2023-04-14 Fresenius Kabi Ipsum S R L Procedimiento para la fabricación de análogos de GLP-1
TWI738260B (zh) 2019-03-25 2021-09-01 台灣神隆股份有限公司 純化利拉魯肽之方法
CN114401981A (zh) * 2019-06-18 2022-04-26 北京费森尤斯卡比医药有限公司 胰高血糖素制造方法
EP3753946A1 (en) 2019-06-18 2020-12-23 Fresenius Kabi iPSUM S.r.l. Improved process for the preparation of high purity glucagon
US20230406900A1 (en) * 2022-06-01 2023-12-21 Scinopharm Taiwan, Ltd. Process for preparing glucagon-like peptide-1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281335B1 (en) * 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
US5705483A (en) * 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
EP0820296A4 (en) * 1995-04-14 1999-06-30 Univ Tulane ANALOGS OF THE GROWTH HORMONE-RELEASING FACTOR
UA65549C2 (uk) * 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
US6903186B1 (en) * 1998-12-07 2005-06-07 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S Analogues of GLP-1
US6514500B1 (en) * 1999-10-15 2003-02-04 Conjuchem, Inc. Long lasting synthetic glucagon like peptide {GLP-!}
US7238671B2 (en) 2001-10-18 2007-07-03 Bristol-Myers Squibb Company Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
WO2005063792A2 (en) * 2003-12-31 2005-07-14 F. Hoffmann-La Roche Ag Methods for recovering cleaved peptide from a support

Also Published As

Publication number Publication date
CN101563364A (zh) 2009-10-21
WO2007147816A1 (en) 2007-12-27
JP4537495B2 (ja) 2010-09-01
TW200811195A (en) 2008-03-01
KR101087859B1 (ko) 2011-11-30
CL2007001835A1 (es) 2008-03-14
EP2035451B1 (en) 2010-05-05
US20110213082A1 (en) 2011-09-01
RS51281B (sr) 2010-12-31
MA30530B1 (fr) 2009-06-01
PT2035451E (pt) 2010-06-09
AU2007263043A1 (en) 2007-12-27
JP2009541257A (ja) 2009-11-26
RU2448978C2 (ru) 2012-04-27
ATE466881T1 (de) 2010-05-15
EP2035451A1 (en) 2009-03-18
UA96602C2 (ru) 2011-11-25
ES2341588T3 (es) 2010-06-22
TWI331155B (en) 2010-10-01
IL195421A0 (en) 2011-08-01
BRPI0713575A2 (pt) 2013-02-13
ZA200810072B (en) 2009-12-30
AU2007263043B2 (en) 2012-11-29
NZ573093A (en) 2012-01-12
CY1110186T1 (el) 2015-01-14
CA2654610A1 (en) 2007-12-27
DE602007006310D1 (da) 2010-06-17
CA2654610C (en) 2012-03-20
AR061604A1 (es) 2008-09-10
NO20084863L (no) 2009-01-22
SI2035451T1 (sl) 2010-06-30
US20080004429A1 (en) 2008-01-03
ECSP088999A (es) 2009-01-30
MY144608A (en) 2011-10-14
RU2009101969A (ru) 2010-07-27
CR10463A (es) 2009-02-26
PL2035451T3 (pl) 2010-08-31
CN101563364B (zh) 2014-04-02
HRP20100302T1 (hr) 2010-06-30
MX2008015935A (es) 2009-01-13
KR20090023619A (ko) 2009-03-05

Similar Documents

Publication Publication Date Title
DK2035451T3 (da) Insulinoptrop peptidsyntese
DK2046826T3 (da) Exendin-fusionsproteiner
DE602006019782D1 (de) Kapselperforationsmodul
DE602007002544D1 (de) Nuancierungsmittel
DE602007003893D1 (de) Kippambossanordnung
DE602007006947D1 (de) Pyridopyrimidinonderivate
DE602007000258D1 (de) Kassetteneinspannmechanismus
DE602006020192D1 (de) Riemenscheibenanorndung
DE602007001280D1 (de) Getränkeextraktor
DK1849352T3 (da) Mejetærsker
AT504580A3 (de) Scan-einrichtung
BRPI0911743A2 (pt) "peptídeo"
DE602007008400D1 (de) Kaliummonopersulfatlösungen
DE602006019150D1 (de) Riemenscheibenanorndung
ATE546437T1 (de) Aminomethyl-4-imidazole
DE502007000218D1 (de) nsetzungen
DE502007002453D1 (de) Kunstoffverdichtergehäuse
DE602007000501D1 (de) Breitbandrichtkoppler
DE602006016174D1 (de) Blisterverpackungsverfahren
DE602007007460D1 (de) Sehkrafttestsystem
DE602007004080D1 (de) Tintenstrahlaufnehmer
DE502007000361D1 (de) Stanznieteinheit
DE502007001629D1 (de) Rfahren
DE602007000333D1 (de) Napfbefestigungsvorrichtung
DE102006045567A8 (de) Crimpstabilisierung